ACE and heart failure: The inclusion criteria specifically targeted studies evaluating key outcomes such as all-cause mortality, cardiovascular mortality, heart failure hospitalizations, and other long-term outcomes related to the effectiveness of beta-blockers and ACE inhibitors.